Copyright Reports & Markets. All rights reserved.

Global Coartem (Artemether/Lumefantrine) Market Research Report 2021

Request for Sample of this report
Buy now

1 Coartem (Artemether/Lumefantrine) Market Overview

  • 1.1 Product Overview and Scope of Coartem (Artemether/Lumefantrine)
  • 1.2 Coartem (Artemether/Lumefantrine) Segment by Type
    • 1.2.1 Global Coartem (Artemether/Lumefantrine) Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Artemether
    • 1.2.3 Lumefantrine
  • 1.3 Coartem (Artemether/Lumefantrine) Segment by Application
    • 1.3.1 Coartem (Artemether/Lumefantrine) Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital Pharmacy
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Online Pharmacy
  • 1.4 Global Coartem (Artemether/Lumefantrine) Market Size Estimates and Forecasts
    • 1.4.1 Global Coartem (Artemether/Lumefantrine) Revenue 2016-2027
    • 1.4.2 Global Coartem (Artemether/Lumefantrine) Sales 2016-2027
    • 1.4.3 Coartem (Artemether/Lumefantrine) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Coartem (Artemether/Lumefantrine) Market Competition by Manufacturers

  • 2.1 Global Coartem (Artemether/Lumefantrine) Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Coartem (Artemether/Lumefantrine) Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Coartem (Artemether/Lumefantrine) Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Coartem (Artemether/Lumefantrine) Manufacturing Sites, Area Served, Product Type
  • 2.5 Coartem (Artemether/Lumefantrine) Market Competitive Situation and Trends
    • 2.5.1 Coartem (Artemether/Lumefantrine) Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Coartem (Artemether/Lumefantrine) Players Market Share by Revenue
    • 2.5.3 Global Coartem (Artemether/Lumefantrine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coartem (Artemether/Lumefantrine) Retrospective Market Scenario by Region

  • 3.1 Global Coartem (Artemether/Lumefantrine) Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Coartem (Artemether/Lumefantrine) Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Coartem (Artemether/Lumefantrine) Market Facts & Figures by Country
    • 3.3.1 North America Coartem (Artemether/Lumefantrine) Sales by Country
    • 3.3.2 North America Coartem (Artemether/Lumefantrine) Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Coartem (Artemether/Lumefantrine) Market Facts & Figures by Country
    • 3.4.1 Europe Coartem (Artemether/Lumefantrine) Sales by Country
    • 3.4.2 Europe Coartem (Artemether/Lumefantrine) Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Coartem (Artemether/Lumefantrine) Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Coartem (Artemether/Lumefantrine) Sales by Region
    • 3.5.2 Asia Pacific Coartem (Artemether/Lumefantrine) Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Coartem (Artemether/Lumefantrine) Market Facts & Figures by Country
    • 3.6.1 Latin America Coartem (Artemether/Lumefantrine) Sales by Country
    • 3.6.2 Latin America Coartem (Artemether/Lumefantrine) Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Coartem (Artemether/Lumefantrine) Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Coartem (Artemether/Lumefantrine) Sales by Country
    • 3.7.2 Middle East and Africa Coartem (Artemether/Lumefantrine) Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Coartem (Artemether/Lumefantrine) Historic Market Analysis by Type

  • 4.1 Global Coartem (Artemether/Lumefantrine) Sales Market Share by Type (2016-2021)
  • 4.2 Global Coartem (Artemether/Lumefantrine) Revenue Market Share by Type (2016-2021)
  • 4.3 Global Coartem (Artemether/Lumefantrine) Price by Type (2016-2021)

5 Global Coartem (Artemether/Lumefantrine) Historic Market Analysis by Application

  • 5.1 Global Coartem (Artemether/Lumefantrine) Sales Market Share by Application (2016-2021)
  • 5.2 Global Coartem (Artemether/Lumefantrine) Revenue Market Share by Application (2016-2021)
  • 5.3 Global Coartem (Artemether/Lumefantrine) Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Novartis
    • 6.1.1 Novartis Corporation Information
    • 6.1.2 Novartis Description and Business Overview
    • 6.1.3 Novartis Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Novartis Product Portfolio
    • 6.1.5 Novartis Recent Developments/Updates
  • 6.2 Sanofi-Aventis
    • 6.2.1 Sanofi-Aventis Corporation Information
    • 6.2.2 Sanofi-Aventis Description and Business Overview
    • 6.2.3 Sanofi-Aventis Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi-Aventis Product Portfolio
    • 6.2.5 Sanofi-Aventis Recent Developments/Updates
  • 6.3 KPC Pharmaceuticals, Inc
    • 6.3.1 KPC Pharmaceuticals, Inc Corporation Information
    • 6.3.2 KPC Pharmaceuticals, Inc Description and Business Overview
    • 6.3.3 KPC Pharmaceuticals, Inc Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 KPC Pharmaceuticals, Inc Product Portfolio
    • 6.3.5 KPC Pharmaceuticals, Inc Recent Developments/Updates
  • 6.4 Guangxi Xiancaotang Pharmaceutical Co., LTD
    • 6.4.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Corporation Information
    • 6.4.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Description and Business Overview
    • 6.4.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Product Portfolio
    • 6.4.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments/Updates
  • 6.5 Guilin Pharmaceutical Co., Ltd
    • 6.5.1 Guilin Pharmaceutical Co., Ltd Corporation Information
    • 6.5.2 Guilin Pharmaceutical Co., Ltd Description and Business Overview
    • 6.5.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Guilin Pharmaceutical Co., Ltd Product Portfolio
    • 6.5.5 Guilin Pharmaceutical Co., Ltd Recent Developments/Updates
  • 6.6 Kerui Nanhai Pharmaceutical
    • 6.6.1 Kerui Nanhai Pharmaceutical Corporation Information
    • 6.6.2 Kerui Nanhai Pharmaceutical Description and Business Overview
    • 6.6.3 Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Kerui Nanhai Pharmaceutical Product Portfolio
    • 6.6.5 Kerui Nanhai Pharmaceutical Recent Developments/Updates
  • 6.7 Kunming Pharmaceutical
    • 6.6.1 Kunming Pharmaceutical Corporation Information
    • 6.6.2 Kunming Pharmaceutical Description and Business Overview
    • 6.6.3 Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Kunming Pharmaceutical Product Portfolio
    • 6.7.5 Kunming Pharmaceutical Recent Developments/Updates

7 Coartem (Artemether/Lumefantrine) Manufacturing Cost Analysis

  • 7.1 Coartem (Artemether/Lumefantrine) Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Coartem (Artemether/Lumefantrine)
  • 7.4 Coartem (Artemether/Lumefantrine) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Coartem (Artemether/Lumefantrine) Distributors List
  • 8.3 Coartem (Artemether/Lumefantrine) Customers

9 Coartem (Artemether/Lumefantrine) Market Dynamics

  • 9.1 Coartem (Artemether/Lumefantrine) Industry Trends
  • 9.2 Coartem (Artemether/Lumefantrine) Growth Drivers
  • 9.3 Coartem (Artemether/Lumefantrine) Market Challenges
  • 9.4 Coartem (Artemether/Lumefantrine) Market Restraints

10 Global Market Forecast

  • 10.1 Coartem (Artemether/Lumefantrine) Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Coartem (Artemether/Lumefantrine) by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Coartem (Artemether/Lumefantrine) by Type (2022-2027)
  • 10.2 Coartem (Artemether/Lumefantrine) Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Coartem (Artemether/Lumefantrine) by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Coartem (Artemether/Lumefantrine) by Application (2022-2027)
  • 10.3 Coartem (Artemether/Lumefantrine) Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Coartem (Artemether/Lumefantrine) by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Coartem (Artemether/Lumefantrine) by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Artemether
    Lumefantrine

    Segment by Application
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Novartis
    Sanofi-Aventis
    KPC Pharmaceuticals, Inc
    Guangxi Xiancaotang Pharmaceutical Co., LTD
    Guilin Pharmaceutical Co., Ltd
    Kerui Nanhai Pharmaceutical
    Kunming Pharmaceutical

    Buy now